Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Assets Average: 2011-2024

Historic Assets Average for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Dec 2024 value amounting to $411.0 million.

  • Ironwood Pharmaceuticals' Assets Average fell 5.88% to $369.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.5 million, marking a year-over-year decrease of 5.88%. This contributed to the annual value of $411.0 million for FY2024, which is 47.70% down from last year.
  • Ironwood Pharmaceuticals' Assets Average amounted to $411.0 million in FY2024, which was down 47.70% from $785.8 million recorded in FY2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Assets Average peaked at $1.1 billion during FY2022, and registered a low of $411.0 million during FY2024.
  • Its 3-year average for Assets Average is $770.2 million, with a median of $785.8 million in 2023.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Assets Average soared by 75.28% in 2021, and later plummeted by 47.70% in 2024.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Assets Average stood at $481.0 million in 2020, then surged by 75.28% to $843.1 million in 2021, then soared by 32.10% to $1.1 billion in 2022, then declined by 29.44% to $785.8 million in 2023, then slumped by 47.70% to $411.0 million in 2024.